Designing aggregated functional RNA medicine
| Project/Area Number |
24655150
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Chemistry related to living body
|
|---|
| Research Institution | Toyohashi University of Technology |
|---|
Principal Investigator |
UMEKAGE SO 豊橋技術科学大学, 工学(系)研究科(研究院), 講師 (30419436)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2014: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2013: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
|
|---|
| Keywords | RNA / RNase / 凝集 / RNA医薬 / 核酸 / RNA分解酵素 / ハンマーヘッドリボザイム |
|---|
| Outline of Final Research Achievements |
RNA is well known to be labile against nucleases attack, and it is assumed that using artificial ribonucleotides is inevitable for obtaining nuclease-resistance when preparing RNA therapeutics. In this research, we tried to obtain ribonuclease-resistant RNA transcripts by using only natural ribonucleotides. We found that in vitro transcripted RNA aggregated when meeting some specific conditions and these aggregates obtained both thermostable and ribonuclease-resistance. Also we showed that this aggregation depended on the length of DNA template and RNA contents. These findings will give significant insight into RNA engineering and/or RNA therapeutics when preparing functional RNAs.
|
Report
(4 results)
Research Products
(13 results)
